ID21653A - Komposisi untuk pengobatan atau pencegahan pankreatitis yang mengandung turunan diarilalkana sebagai bahan aktif - Google Patents

Komposisi untuk pengobatan atau pencegahan pankreatitis yang mengandung turunan diarilalkana sebagai bahan aktif

Info

Publication number
ID21653A
ID21653A IDW990414A ID990414A ID21653A ID 21653 A ID21653 A ID 21653A ID W990414 A IDW990414 A ID W990414A ID 990414 A ID990414 A ID 990414A ID 21653 A ID21653 A ID 21653A
Authority
ID
Indonesia
Prior art keywords
diarilalkana
prevention
composition
active materials
pancreatitic
Prior art date
Application number
IDW990414A
Other languages
English (en)
Indonesian (id)
Inventor
Fumitoshi Asai
Koichi Fujimoto
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of ID21653A publication Critical patent/ID21653A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW990414A 1996-11-28 1997-11-27 Komposisi untuk pengobatan atau pencegahan pankreatitis yang mengandung turunan diarilalkana sebagai bahan aktif ID21653A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31774696 1996-11-28

Publications (1)

Publication Number Publication Date
ID21653A true ID21653A (id) 1999-07-08

Family

ID=18091579

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990414A ID21653A (id) 1996-11-28 1997-11-27 Komposisi untuk pengobatan atau pencegahan pankreatitis yang mengandung turunan diarilalkana sebagai bahan aktif

Country Status (12)

Country Link
EP (1) EP0958817A1 (hu)
KR (1) KR20000057309A (hu)
CN (1) CN1245426A (hu)
AU (1) AU717679B2 (hu)
CA (1) CA2273085A1 (hu)
CZ (1) CZ189299A3 (hu)
HU (1) HUP9904002A3 (hu)
ID (1) ID21653A (hu)
IL (1) IL130103A0 (hu)
NO (1) NO992552L (hu)
NZ (1) NZ336003A (hu)
WO (1) WO1998023271A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090093493A1 (en) * 2007-10-09 2009-04-09 Francesco Berardi 1-phenylalcoxy-2-beta-phenylethyl derivatives as p-glycoprotein (p-gp) inhibitors useful in drug resistance events

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0441472A (ja) * 1990-06-05 1992-02-12 Sankyo Co Ltd グアニジノ安息香酸エステル誘導体
CA2110251A1 (en) * 1992-11-30 1994-05-31 Koichi Fujimoto Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis
JP3154884B2 (ja) * 1992-12-18 2001-04-09 三共株式会社 脂環式アミン誘導体

Also Published As

Publication number Publication date
HUP9904002A2 (hu) 2000-04-28
NO992552L (no) 1999-07-19
KR20000057309A (ko) 2000-09-15
AU717679B2 (en) 2000-03-30
IL130103A0 (en) 2000-06-01
EP0958817A1 (en) 1999-11-24
AU5067198A (en) 1998-06-22
HUP9904002A3 (en) 2001-01-29
CZ189299A3 (cs) 1999-09-15
NO992552D0 (no) 1999-05-27
CN1245426A (zh) 2000-02-23
NZ336003A (en) 2001-02-23
CA2273085A1 (en) 1998-06-04
WO1998023271A1 (fr) 1998-06-04

Similar Documents

Publication Publication Date Title
ID16493A (id) Perlakuan bahan yang mengandung padatan yang diambil dari efluen
HUP0103621A3 (en) Fentanyl composition for the treatment of acute pain
DE69739583D1 (de) Topische zusammensetzungen enthaltend als therapeutisch aktiven wirkstoff ein monoglycerid zur behandlung von schleimhautinfektionen
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
ID19520A (id) Formulasi-formulasi aerosol untuk pengobatan yang mengandung formoterol
FI964338A0 (fi) Sellulaasia sisältäviä kankaanhoitoainekoostumuksia
ID22878A (id) Komposisi aktif secara terapi
DE69513916D1 (de) Oberflächenbehandlungszusammensetzung
DE69731542D1 (de) Photokatalytische zusammensetzung
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
IT1289581B1 (it) Miscela,composizione per la protezione delle piante contenente la miscela e suo impiego
BR9706908A (pt) Composiçães para o tratamento de insuficiéncia renal compreendendo l-carnosina
ID17478A (id) Komposisi pembersih antimikrobial yang sudah disempurnakan
DE69622461D1 (de) Oberflächenbehandlungszusammensetzung
ID16154A (id) Komposisi monomer yang distabilisasi
IS4789A (is) Meðferðarefnasambönd
ZA97252B (en) Compositions for the prevention and treatment of osteoporosis.
ID23373A (id) Komposisi-komposisi farmasi yang mengandung turunan-turunan n-sulfonilindolin
ZA948176B (en) Compositions for the treatment of industrial water
DE69605988D1 (de) Synergistische antimikrobielle Zusammensetzung
NO982562D0 (no) Sammensetning for behandling av smerte
BR9610382A (pt) Composição de tratamento do cableo
ID21653A (id) Komposisi untuk pengobatan atau pencegahan pankreatitis yang mengandung turunan diarilalkana sebagai bahan aktif
BR9703562A (pt) Composiçoes para tratamento de água
AP9700928A0 (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections